Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 3841 AL 3855

[Innovation in diagnostics-mobile technologies]

Düzel E, Thyrian JR, Berron D.

Nervenarzt. 2019 Sep;90(9):914-920. doi: 10.1007/s00115-019-0773-8.

Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

Cummings J, Passmore P, McGuinness B, Mok V, Chen C, Engelborghs S, Woodward M, Manzano S, Garcia-Ribas G, Cappa S, Bertolucci P, Chu LW.

Alzheimers Res Ther. 2019 Aug 17;11(1):73. doi: 10.1186/s13195-019-0528-6.

Misdiagnosis leads to Iatrogenesis

Chin AV.

Med J Malaysia. 2019 Aug;74(4):359-362.

Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline

Wanleenuwat P, Iwanowski P, Kozubski W.

Postgrad Med. 2019 Sep;131(7):415-422. doi: 10.1080/00325481.2019.1657776. Epub 2019 Aug 27.

Effectiveness of using assistive technology for time orientation and memory, in older adults with or without dementia

Nishiura Y, Nihei M, Nakamura-Thomas H, Inoue T.

Disabil Rehabil Assist Technol. 2021 Jul;16(5):472-478. doi: 10.1080/17483107.2019.1650299. Epub 2019 Aug 19.

Modifiable Risk Factors Explain Socioeconomic Inequalities in Dementia Risk: Evidence from a Population-Based Prospective Cohort Study

Deckers K, Cadar D, van Boxtel MPJ, Verhey FRJ, Steptoe A, Köhler S.

J Alzheimers Dis. 2019;71(2):549-557. doi: 10.3233/JAD-190541.

Comparison of the risk for dementia between physicians and the general population: a nationwide population-based cohort study

Ma LJ, Wu TM, Feng IJ, Hsu CC, Su SB, Wang JJ, Huang CC.

Aging Clin Exp Res. 2020 Jun;32(6):1111-1119. doi: 10.1007/s40520-019-01278-4. Epub 2019 Aug 19.

Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies

Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, Yu JT.

Ageing Res Rev. 2019 Nov;55:100944. doi: 10.1016/j.arr.2019.100944. Epub 2019 Aug 17.

[Prevention of cognitive decline and dementia by treatment of risk factors]

Escher C, Jessen F.

Nervenarzt. 2019 Sep;90(9):921-925. doi: 10.1007/s00115-019-0759-6.

Vascular cognitive impairment associated with NOTCH3 Exon 33 mutation: A case report

Sun Y, Wei YJ, Xing Y.

Medicine (Baltimore). 2019 Aug;98(34):e16920. doi: 10.1097/MD.0000000000016920.

Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality

Taylor MK, Swerdlow RH, Sullivan DK.

Nutrients. 2019 Aug 15;11(8):1910. doi: 10.3390/nu11081910.

Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study

Cosseddu M, Benussi A, Gazzina S, Alberici A, Dell'Era V, Manes M, Cristillo V, Borroni B, Padovani A.

Eur J Neurol. 2020 Feb;27(2):265-272. doi: 10.1111/ene.14071. Epub 2019 Sep 18.

[Visual perceptual disorders in Alzheimer's disease]

Lenoir H, Siéroff É.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Sep 1;17(3):307-316. doi: 10.1684/pnv.2019.0815.

Geospatial Analysis of Environmental Risk Factors for Missing Dementia Patients

Puthusseryppady V, Coughlan G, Patel M, Hornberger M.

J Alzheimers Dis. 2019;71(3):1005-1013. doi: 10.3233/JAD-190244.

Awareness of Self and Disease Assessment: Development and Validation of a Subjective Measure in People with Alzheimer's Disease

Mayelle A, El Haj M, Antoine P.

J Alzheimers Dis. 2019;71(3):841-850. doi: 10.3233/JAD-190371.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias